Predicting tumors that respond to immune checkpoint inhibitors early in treatment
Monday, May 1, 2017 - 09:32
in Health & Medicine
A noninvasive PET imaging method that measures granzyme B, a protein released by immune cells to kill cancer cells, was able to distinguish mouse and human tumors that responded to immune checkpoint inhibitors from those that did not respond early in the course of treatment.